Expression of Concern: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial
Frontiers Editorial OfficeAn Expression of Concern on
Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial
by Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., et al. (2016). Front. Aging Neurosci. 8:256. doi: 10.3389/fnagi.2016.00256
With this notice, Frontiers states its awareness of concerns regarding the validity of the participant data in this study. An investigation is currently being conducted by Kashan University of Medical Sciences research ethics committee. This expression of concern has been posted while Frontiers awaits the outcome of that investigation and will then be updated accordingly.
Citation: Frontiers Editorial Office (2020) Expression of Concern: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front. Aging Neurosci. 12:602204. doi: 10.3389/fnagi.2020.602204
Received: 02 September 2020; Accepted: 02 September 2020;
Published: 07 October 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org